The Drosophila hep pathway mediates Lrrk2-induced neurodegeneration

Dejun Yang1, Joseph M Thomas2, Tianxia Li2

  • 1a Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Insights

Mutations in leucine-rich repeat kinase 2 (Lrrk2) cause familial Parkinson's disease (PD). This study found that inhibiting the hemipterous (hep) pathway in a fly model suppressed PD-like symptoms, suggesting a therapeutic target.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Mutations in leucine-rich repeat kinase 2 (Lrrk2) are a significant cause of familial Parkinson's disease (PD).
  • The precise signaling pathways driving Lrrk2-associated neurodegeneration remain incompletely understood.
  • Evidence suggests a functional link between Lrrk2 and mitogen-activated protein kinase (MAPK) signaling cascades.

Purpose of the Study:

  • To investigate the in vivo relationship between Lrrk2 function and MAPK pathways in Parkinson's disease pathogenesis.
  • To identify genetic modifiers that can ameliorate phenotypes associated with G2019S-Lrrk2 mutations using a Drosophila model.

Main Methods:

  • Conducted genetic RNA interference (RNAi) screens targeting MAPK pathways in a Drosophila model of G2019S-Lrrk2-induced Parkinson's disease.
  • Assessed the impact of gene knockdown and dominant-negative constructs on fly survival, locomotion, and dopaminergic neuron integrity.
  • Utilized a JNK inhibitor (SP600125) to evaluate the therapeutic potential of targeting downstream signaling.

Main Results:

  • Knockdown of hemipterous (hep, also known as JNKK) significantly improved survival, locomotor activity, and preserved dopaminergic neurons in flies expressing G2019S-Lrrk2.
  • Expression of a dominant-negative JNK construct mimicked the protective effects of hep knockdown.
  • Pharmacological inhibition of JNK signaling partially reversed neurodegeneration caused by G2019S-Lrrk2.

Conclusions:

  • The hemipterous (hep) pathway plays a critical role in the pathogenesis of Lrrk2-linked Parkinson's disease in a Drosophila model.
  • These findings elucidate molecular mechanisms underlying Lrrk2-associated neurodegeneration.
  • The hep/JNK pathway represents a potential therapeutic target for Parkinson's disease treatment.

Related Concept Videos